VRSN
50
-3
HCP
34
6
CHK
45
-5
ROP
57
-6
MRO
56
-2
MAS
59
4
KEY
64
6
MA
60
-2
AVGO
32
-3
PX
25
5
MSI
61
-3
WM
59
2
SYK
42
3
PFE
26
3
GILD
59
3
AKAM
70
12
APD
47
-3
JPM
60
-2
ADI
54
-3
JCI
47
2
VRSN
50
-3
HCP
34
6
CHK
45
-5
ROP
57
-6
MRO
56
-2
MAS
59
4
KEY
64
6
MA
60
-2
AVGO
32
-3
PX
25
5
MSI
61
-3
WM
59
2
SYK
42
3
PFE
26
3
GILD
59
3
AKAM
70
12
APD
47
-3
JPM
60
-2
ADI
54
-3
JCI
47
2
Financhill
Back

Immunovant Stock Predictions

#1 Low-Priced Lithium Stock as Global EV Sales Accelerate

Find out more here.
Buy
88

IMVT
Immunovant

Last Price:
39.14
Seasonality Move:
-5.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Tiny Lithium Stock Gets $90M Boost in Global EV Battery Race

Learn more here.

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 126.3% based on the past 4 years of stock performance.
  • Immunovant has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $39.11. The Score for IMVT is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.
  • IMVT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 126.3% based on the past 4 years of stock performance.

Immunovant Stock Rating

Buy
88
Immunovant (IMVT) is a Buy

Is Immunovant overpriced?

  • Immunovant has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMVT is experiencing slight selling pressure.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
44.19
52-Week Low:
12.77

Prediction Charts

Market Cap:
5.66B
Price in USD:
39.11
Volume:
2.62M
Beta:
0.72

Technical Analysis

SMA50:
34.28
SMA100:
28.04
SMA200:
23.02
52-Wk Change:
198.32%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 39.11 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-10 31.84 32.63 32.82 31.52
Nov-13 32.37 32.80 33.35 31.60
Nov-14 34.24 34.97 35.00 33.83
Nov-15 34.97 34.25 35.91 34.24
Nov-16 33.80 33.72 34.44 33.44
Nov-17 34.05 33.79 34.40 33.62
Nov-20 34.28 33.80 35.09 33.66
Nov-21 33.27 32.96 33.90 32.95
Nov-22 33.30 32.68 34.08 32.36
Nov-24 32.63 33.42 34.15 32.49
Nov-27 33.42 33.54 33.70 31.84
Nov-28 34.52 36.01 36.81 32.34
Nov-29 36.18 38.24 40.00 36.16
Nov-30 38.81 39.11 40.90 38.47

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.22 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.